Status:
COMPLETED
Safety and Efficacy of Dinoprostone (Propess) in the Women With Premature Rupture of Membrane or Gestational Age <38
Lead Sponsor:
Seoul National University Hospital
Conditions:
Induction of Labor
Eligibility:
FEMALE
20-50 years
Phase:
PHASE2
Brief Summary
Dinoprostone(propess) is commonly used for induction of labor in the pregnant women who has intact membrane after 38weeks of gestational age. The investigators study safety and efficacy of dinoproston...
Eligibility Criteria
Inclusion
- Pregnant women who admitted for induction of labor
- Bishop score \<= 6
Exclusion
- Contraindication to induction of labor
- Active labor
- Vaginal bleeding, unknown origin
- Hypersensitive to Prostaglandin E
- History of asthma, glaucoma
- Infection (birth canal)
- Placental abruption
- Multiparity(\>5)
- Pelvic inflammatory disease
- Heart, lung, kidney disease
- Multiple pregnancy
- Major anomaly
- Fetal distress before induction of labor
Key Trial Info
Start Date :
August 25 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 4 2019
Estimated Enrollment :
189 Patients enrolled
Trial Details
Trial ID
NCT01916291
Start Date
August 25 2013
End Date
April 4 2019
Last Update
March 24 2020
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Hospital
Seoul, South Korea, 110744
2
Seoul Metropolitan Goverment Seoul National University Boramae Medical Center
Seoul, South Korea, 156707